IMA ImageneBio, Inc. - Common Stock
$5,59
Prezzo · Ago 18, 2026
Fondamentali al Ago 5, 2026
Intervallo 52 sett.
$4–$14
16% of range
Rating Analisti
STRONG BUY
7 analysts
Prezzo Obiettivo
$13
+133% upside
P/E (TTM)
-0.7
ROE
192.1%
Margine di Profitto Netto
-5668.6%
IMA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$5.59
Capitalizzazione di Mercato
—
P/E (TTM)
-0.7
EPS (TTM)
$-9.64
Ricavi (TTM)
$800.0K
Rendimento div.
—
ROE
192.1%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$4 – $14
IMA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$800.0K
2020-12-31
→
2025-12-31
EPS
$-9.64
2021-12-31
→
2025-12-31
Flusso di cassa libero
—
2021-12-31
→
2023-12-31
Margini
-5668.6%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
IMA
Mediana dei peer
P/E (TTM)
-0.7
44.2
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
IMA
Mediana dei peer
Operating Margin (Margine Operativo)
-6056.4%
—
Net Profit Margin (Margine di Profitto Netto)
-5668.6%
-30.5%
ROA
-53.7%
-54.4%
ROE
192.1%
-87.0%
ROIC
-36.1%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
IMA
Mediana dei peer
Current Ratio (Rapporto corrente)
12.5
2.0
Quick Ratio
12.0
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
IMA
Mediana dei peer
Revenue YoY (Ricavi YoY)
-77.1%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
-62.9%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
-38.6%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
IMA
Mediana dei peer
IMA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
7 analisti
- Acquisto forte 3 42,9%
- Compra 2 28,6%
- Mantieni 1 14,3%
- Vendi 0 0,0%
- Vendita forte 1 14,3%
Target Price a 12 Mesi
2 analisti · 2026-08-19
Mediana
$13.00
Ora
$5.59
Basso
$2.00
Alto
$24.00
Target mediano
$13.00
+132,6%
Target medio
$13.00
+132,6%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.03%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-0.63 | $-0.90 | 0.27% |
| 31 Marzo 2026 | $-0.95 | $-0.71 | -0.24% |
| 31 Dicembre 2025 | $-1.42 | $-1.46 | 0.04% |
| 30 Settembre 2025 | $-2.91 | $-1.29 | -1.6% |
| 30 Giugno 2025 | $-0.72 | $-1.70 | 0.98% |
| 31 Marzo 2025 | $-2.16 | $-2.55 | 0.39% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| IMA | — | -0.7 | -77.1% | -5668.6% | 192.1% | — |
| CING | — | — | — | — | — | — |
| ELOX | — | — | — | — | 30.1% | — |
| TELO | $46M | -4.0 | — | — | -325.7% | — |
| PLRX | $75M | -0.5 | -83.7% | — | -74.4% | — |
| TLPH | $56M | — | — | -51035.7% | -120.8% | — |
| BSEM | — | — | — | — | — | — |
| SCLX | — | — | — | — | — | — |
| SCYX | $28M | -3.7 | 450.0% | -41.8% | -18.4% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $800.0K | $4M | $9M | $16M | $31M | $9M | |
| R&D Expense | $29M | $32M | $60M | $64M | $47M | $45M | |
| SG&A Expense | $21M | $8M | $25M | $22M | $18M | $9M | |
| Operating Expenses | $49M | $40M | $85M | $87M | $65M | $54M | |
| Operating Income | $-48M | $-37M | $-75M | $-71M | $-34M | $-45M | |
| Interest Income | · | · | $7M | $2M | $23.0K | · | |
| Other Non-op | $717.0K | $71.0K | $-22.0K | $2M | $23.0K | $263.0K | |
| Pretax Income | $-46M | $-37M | $-68M | $-69M | · | · | |
| Income Tax | $-350.0K | $13.0K | $-162.0K | $0 | $0 | · | |
| Net Income | $-45M | $-37M | $-68M | $-69M | $-34M | $-44M | |
| EPS (Basic) | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 | · | |
| EPS (Diluted) | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 | · | |
| Shares (Basic) | 4,870,906 | 1,194,172 | 41,735,081 | 36,188,420 | 27,983,359 | · | |
| Shares (Diluted) | · | 48,258,111 | 41,735,081 | 36,188,420 | 27,983,359 | · | |
| EBITDA | $-48M | $-59M | $-75M | $-71M | $-34M | · |
Stato Patrimoniale 22
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $95M | $12M | $120M | $60M | $232M | $162M | |
| Short-term Investments | $41M | $0 | $56M | $97M | · | · | |
| Prepaid Expense | $5M | $350.0K | $3M | $3M | $4M | $3M | |
| Other Current Assets | · | · | $1M | $964.0K | $629.0K | $2M | |
| Current Assets | $140M | $12M | $179M | $160M | $237M | $166M | |
| PP&E (Net) | $0 | $8.0K | $2M | $3M | $2M | $1M | |
| PP&E (Gross) | $0 | $341.0K | $5M | $5M | $4M | $2M | |
| Accum. Depreciation | $0 | $333.0K | $3M | $2M | $1M | $688.0K | |
| Other Non-current Assets | $5M | $1M | · | · | · | $872.0K | |
| Total Assets | $153M | $16M | $192M | $172M | $248M | $168M | |
| Accounts Payable | $1M | $5M | $2M | $2M | $2M | $2M | |
| Current Liabilities | $11M | $17M | $14M | $22M | $27M | $28M | |
| Capital Leases | $713.0K | $239.0K | $7M | $4M | $5M | $0 | |
| Other Non-current Liabilities | $870.0K | $0 | $950.0K | · | · | · | |
| Total Liabilities | $20M | $17M | $22M | $25M | $40M | $63M | |
| Common Stock | · | $48.0K | $48.0K | $36.0K | $36.0K | $3.0K | |
| Paid-in Capital | $363M | $2M | $452M | $362M | $353M | $10M | |
| Retained Earnings | $-230M | $-180M | $-282M | $-214M | $-145M | $-111M | |
| AOCI | $87.0K | $-2M | $-48.0K | $-763.0K | · | · | |
| Stockholders' Equity | $133M | $-161M | $-126M | $147M | $208M | $-101M | |
| Liabilities + Equity | $153M | $16M | $192M | $172M | $248M | $168M | |
| Shares Outstanding | · | 48,258,111 | 48,258,111 | 36,257,493 | 35,975,034 | 3,096,903 |
Flusso di cassa 17
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $400.0K | $1M | · | · | · | · | |
| Stock-based Comp | $15M | $0 | $8M | $8M | $5M | $2M | |
| Deferred Tax | $0 | $0 | · | · | · | · | |
| Restructuring | · | $4M | · | · | · | · | |
| Other Non-cash | $-18M | · | · | · | · | · | |
| Operating Cash Flow | $-48M | $-21M | $-80M | $-74M | $-60M | $-38M | |
| CapEx | · | · | $414.0K | $1M | $2M | $766.0K | |
| Investing Cash Flow | $-6M | $11M | $64M | $-99M | $-2M | $3M | |
| Debt Issued | $15M | $8M | · | · | · | · | |
| Net Debt Issued | $15M | · | · | · | · | · | |
| Stock Issued | · | · | $37M | · | · | · | |
| Stock Repurchased | · | · | $663.0K | · | · | · | |
| Net Stock Activity | · | · | $-663.0K | · | · | · | |
| Financing Cash Flow | $135M | $7M | $76M | $1M | $132M | $116M | |
| Net Change in Cash | $82M | $-3M | · | · | · | · | |
| Taxes Paid | $23.0K | $221.0K | · | · | · | · | |
| Free Cash Flow | · | · | $-80M | $-76M | $-62M | · |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -6056.4% | · | -823.3% | -454.0% | -110.2% | · | |
| Net Margin | -5668.6% | · | -744.2% | -440.3% | -110.1% | · | |
| Pretax Margin | -5712.4% | · | -745.9% | · | · | · | |
| EBITDA Margin | -6006.4% | · | -823.3% | -454.0% | -110.2% | · | |
| ROA | -53.7% | -29.5% | -37.4% | -32.7% | -16.4% | · | |
| ROE | 192.1% | 367.1% | -41.9% | -45.0% | -16.6% | · | |
| ROIC | -36.1% | -47.0% | -44.3% | · | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 12.5 | 11.8 | 12.6 | 7.4 | 8.7 | · | |
| Quick Ratio | 12.0 | 11.5 | 12.4 | 7.3 | 8.5 | · |
Efficienza 1
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.1 | 0.1 | 0.1 | · |
Tassi di Crescita 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -77.1% | -61.8% | -41.3% | -49.6% | 237.0% | · | |
| Revenue CAGR 3Y | -62.9% | -51.7% | -0.12% | · | · | · | |
| Revenue CAGR 5Y | -38.6% | · | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $800.0K | $4M | $9M | $16M | $31M | · | |
| Net Income TTM | $-45M | $-37M | $-68M | $-69M | $-34M | · | |
| Market Cap | · | $950M | $1.14B | $1.16B | $5.41B | · | |
| P/E | -0.7 | -0.9 | -14.5 | -16.8 | -123.3 | · | |
| P/S | · | 271.3 | 124.5 | 74.1 | 174.7 | · | |
| P/B | · | 7.5 | 6.7 | 7.9 | 26.0 | · | |
| P / Tangible Book | · | · | · | 7.9 | 26.0 | · | |
| P / Cash Flow | · | -20.6 | -14.3 | -15.6 | -89.8 | · | |
| P / FCF | · | · | -14.2 | -15.3 | -87.3 | · | |
| Earnings Yield | -139.7% | -112.3% | -6.9% | -5.9% | -0.81% | · |
Conto Economico 15
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | $800.0K | $0 | $4M | · | · | $658.0K | $1M | $2M | $5M | $5M | $6M | |
| R&D Expense | $7M | $6M | $5M | $16M | $6M | $4M | $9M | $4M | $10M | $10M | $14M | $15M | $15M | $16M | $16M | $19M | |
| SG&A Expense | $5M | $6M | $-370.0K | $11M | $2M | $3M | $-5M | $2M | $5M | $6M | $8M | $6M | $5M | $5M | $5M | $5M | |
| Operating Expenses | $12M | $12M | $3M | $27M | $7M | $7M | $915.0K | $6M | $16M | $18M | $23M | $21M | $20M | $21M | $21M | $24M | |
| Operating Income | $-12M | $-12M | $-2M | $-27M | $-7M | $-6M | $-915.0K | $-2M | $-16M | $-18M | $-22M | $-20M | $-18M | $-16M | $-15M | $-18M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $2M | $1M | $730.0K | $967.0K | $550.0K | |
| Other Non-op | $374.0K | $341.0K | $-7M | $2M | $9.0K | $-5.0K | $1M | $-1M | $235.0K | $-7.0K | $-580.0K | $-2.0K | $-6.0K | $566.0K | $1M | $538.0K | |
| Pretax Income | $-10M | $-11M | $-10M | $-25M | $-8M | $-6M | $-4M | $-3M | $-14M | $-16M | $-20M | $-17M | $-17M | $-14M | · | · | |
| Income Tax | $16.0K | $10.0K | $-319.0K | $-74.0K | $15.0K | $28.0K | $-76.0K | $0 | $62.0K | $27.0K | · | · | · | · | · | · | |
| Net Income | $-10M | $-11M | $-7M | $-25M | $-8M | $-6M | $-5M | $-3M | $-6M | $-22M | $-19M | $-17M | $-17M | $-14M | $-14M | $-17M | |
| EPS (Basic) | $-0.63 | $-0.95 | $-6.49 | $-2.91 | $-4.46 | $-3.80 | $-18.91 | $-2.58 | $-0.28 | $-0.33 | $-0.40 | $-0.40 | $-0.44 | $-0.39 | $-0.38 | $-0.48 | |
| EPS (Diluted) | $-0.63 | $-0.95 | $-6.49 | $-2.91 | $-4.46 | $-3.80 | $-18.91 | $-2.58 | $-0.28 | $-0.33 | $-0.40 | $-0.40 | $-0.44 | $-0.39 | $-0.38 | $-0.48 | |
| Shares (Basic) | · | 11,211,268 | -100,172,097 | 8,526,781 | 48,258,111 | 1,409,963 | -96,722,607 | 1,400,557 | 48,258,111 | 48,258,111 | -77,252,966 | 43,437,844 | 39,292,710 | 36,257,493 | -72,305,012 | 36,257,074 | |
| Shares (Diluted) | 16,161,721 | 11,211,268 | · | · | 2,406,516 | 2,404,832 | · | 48,258,111 | 48,258,111 | 48,258,111 | -77,252,966 | 43,437,844 | 39,292,710 | 36,257,493 | -72,305,012 | 36,257,074 | |
| EBITDA | $-12M | $-12M | · | $-27M | $-9M | $-11M | · | $-12M | $-16M | $-18M | · | $-20M | $-18M | $-16M | · | $-18M |
Stato Patrimoniale 22
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $95M | $76M | $95M | $103M | $58M | $37M | $12M | $45M | $44M | $53M | $120M | $121M | $71M | $29M | $60M | $67M | |
| Short-term Investments | $41M | $41M | $41M | $39M | $37M | $77M | $0 | $93M | $101M | $104M | $56M | $76M | $86M | $108M | $97M | $107M | |
| Prepaid Expense | $5M | $5M | $5M | $5M | $3M | $3M | $350.0K | $4M | $4M | $4M | $3M | $4M | $3M | $3M | $3M | $4M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | $731.0K | $1M | $964.0K | $1M | |
| Current Assets | $141M | $122M | $140M | $148M | $99M | $117M | $12M | $142M | $149M | $161M | $179M | $201M | $161M | $141M | $160M | $178M | |
| PP&E (Net) | · | · | $0 | $1.0K | $419.0K | $506.0K | $8.0K | $682.0K | $772.0K | $864.0K | $2M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | · | · | $0 | · | · | · | $341.0K | · | · | · | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | · | · | $0 | · | · | · | $333.0K | · | · | · | $3M | $3M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | $5M | $5M | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Total Assets | $152M | $137M | $153M | $161M | $126M | $131M | $16M | $149M | $157M | $173M | $192M | $215M | $172M | $152M | $172M | $190M | |
| Accounts Payable | $977.0K | $568.0K | $1M | $2M | $512.0K | $805.0K | $5M | $2M | $1M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | |
| Current Liabilities | $7M | $7M | $11M | $11M | $7M | $9M | $17M | $9M | $8M | $10M | $14M | $19M | $12M | $14M | $22M | $25M | |
| Capital Leases | $0 | $110.0K | $713.0K | $1M | $2M | $3M | $239.0K | $4M | $5M | $6M | $7M | $8M | $3M | $3M | $4M | $4M | |
| Other Non-current Liabilities | $838.0K | $881.0K | $870.0K | $1M | $1M | $1M | $0 | $1M | $1M | $964.0K | · | · | · | · | · | · | |
| Total Liabilities | $10M | $13M | $20M | $21M | $10M | $13M | $17M | $15M | $15M | $17M | $22M | $28M | $15M | $17M | $25M | $32M | |
| Common Stock | · | · | · | · | $48.0K | $48.0K | · | $48.0K | $48.0K | $48.0K | $48.0K | $44.0K | $42.0K | $36.0K | $36.0K | $36.0K | |
| Paid-in Capital | $393M | $364M | $363M | $363M | $459M | $458M | $2M | $456M | $455M | $454M | $452M | $418M | $403M | $364M | $362M | $360M | |
| Retained Earnings | $-251M | $-241M | $-230M | $-223M | $-343M | $-340M | $-180M | $-322M | $-312M | $-299M | $-282M | $-263M | $-246M | $-228M | $-214M | $-200M | |
| AOCI | $-51.0K | $-17.0K | $87.0K | $94.0K | $65.0K | $99.0K | $-2M | $240.0K | $-350.0K | $-313.0K | $-48.0K | $-290.0K | $-456.0K | $-491.0K | $-763.0K | $-1M | |
| Stockholders' Equity | $142M | $123M | $133M | $140M | $116M | $118M | $-161M | $134M | $143M | $155M | $170M | $155M | $157M | $135M | $147M | $159M | |
| Liabilities + Equity | $152M | $137M | $153M | $161M | $126M | $131M | $16M | $149M | $157M | $173M | $192M | $215M | $172M | $152M | $172M | $190M | |
| Shares Outstanding | · | · | · | · | 48,258,111 | 48,258,111 | · | 48,258,111 | 48,258,111 | 48,258,111 | 48,258,111 | 44,104,672 | 42,299,478 | 36,257,493 | 36,257,493 | 36,257,493 |
Flusso di cassa 13
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $0 | $0 | $393.0K | $2.0K | $2.0K | $2.0K | $18.0K | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $911.0K | $876.0K | $51.0K | $14M | $458.0K | $57.0K | $0 | $-3M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | $309.0K | $1M | · | $812.0K | $683.0K | $3M | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-15M | $-7M | $-27M | $-3M | $-7M | $-3M | $13M | $-13M | $-18M | $-22M | $-20M | $-18M | $-20M | $-18M | $-17M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $262.0K | $0 | $0 | $152.0K | $231.0K | $1M | |
| Investing Cash Flow | $-346.0K | $-440.0K | $-1M | $-37M | $25M | $0 | $103.0K | $56M | $4M | $-49M | $20M | $32M | $23M | $-11M | $10M | $36M | |
| Debt Issued | · | · | $0 | $0 | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $-123.0K | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $28M | $-3M | $0 | $122M | $13M | $27.0K | $7M | · | · | · | $60.0K | $39M | · | · | $1.0K | $24.0K | |
| Net Change in Cash | $19M | $-18M | $-9M | $97M | $1M | $-7M | $4M | · | · | · | · | · | · | · | · | · | |
| Taxes Paid | · | · | $9.0K | · | · | · | $220.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-20M | · | · |
Redditività 6
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | -1645.8% | -922.6% | -292.0% | · | -279.2% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | -1463.5% | -854.0% | -267.6% | · | -270.8% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | -1645.8% | -922.6% | -292.0% | · | -279.2% | |
| ROA | -7.3% | -7.9% | · | -16.0% | -1.9% | -5.7% | · | -5.6% | -8.3% | -9.9% | · | -8.6% | -8.9% | -7.5% | · | -7.7% | |
| ROE | -7.9% | -8.8% | · | -18.1% | -2.1% | -6.3% | · | -7.1% | -9.2% | -11.1% | · | -11.0% | -10.3% | -8.7% | · | -9.6% | |
| ROIC | -8.3% | -9.8% | · | -19.0% | -7.6% | -9.2% | · | -9.2% | -11.1% | -11.8% | · | · | · | · | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.5 | 18.4 | · | 13.2 | 13.5 | 13.3 | · | 15.3 | 18.2 | 15.8 | · | 10.4 | 13.4 | 10.1 | · | 7.1 | |
| Quick Ratio | 20.7 | 17.7 | · | 12.8 | 13.1 | 13.0 | · | 14.9 | 17.7 | 15.5 | · | 10.2 | 13.1 | 9.9 | · | 7.0 |
Efficienza 1
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | $15M | $15M | · | $15M | $14M | $15M | · | $14M | |
| Net Income TTM | $-53M | $-49M | · | $-42M | $-23M | $-38M | · | $-49M | $-63M | $-71M | · | $-66M | $-69M | $-69M | · | $-69M | |
| Market Cap | · | · | · | · | $776M | $741M | · | $1.00B | $956M | $822M | · | $2.29B | $3.33B | $1.50B | · | $1.54B | |
| P/E | -0.7 | -0.6 | · | -1.4 | -5.2 | -4.6 | · | -5.8 | -13.7 | -10.9 | · | -30.4 | -41.9 | -21.7 | · | -22.2 | |
| P/S | · | · | · | · | · | · | · | · | 64.1 | 55.2 | · | 153.8 | 236.1 | 97.0 | · | 111.0 | |
| P/B | · | · | · | · | 6.7 | 6.3 | · | 7.5 | 6.7 | 5.3 | · | 14.8 | 21.2 | 11.1 | · | 9.7 | |
| P / Tangible Book | · | · | · | · | 6.7 | 6.3 | · | 7.5 | 6.7 | 5.3 | · | 14.8 | 21.2 | 11.1 | · | 9.7 | |
| P / Cash Flow | · | · | · | · | · | -70.2 | · | · | · | -44.9 | · | · | · | -75.9 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -75.3 | · | · | |
| Earnings Yield | -151.7% | -154.4% | · | -70.3% | -19.3% | -21.9% | · | -17.3% | -7.3% | -9.2% | · | -3.3% | -2.4% | -4.6% | · | -4.5% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $800.0K | $4M | $9M | $16M | $31M |
| Margine Operativo % | -6056.4% | — | -823.3% | -454.0% | -110.2% |
| Utile netto | $-45M | $-37M | $-68M | $-69M | $-34M |
| EPS Diluito | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 12.5 | 11.8 | 12.6 | 7.4 | 8.7 |
| Quick Ratio | 12.0 | 11.5 | 12.4 | 7.3 | 8.5 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | — | — | $-80M | $-76M | $-62M |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 36 filer · $36.3M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 7 (+3 vs trimestre precedente) | 8 (+1 vs trimestre precedente) | 6 (-9 vs trimestre precedente) | 11 (+6 vs trimestre precedente) | +1.2M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| BVF INC/IL | $6.549.012 | 1.110.002 | 18,05% | Azioni |
| Blue Owl Capital Holdings LP | $5.414.383 | 917.692 | 14,93% | Azioni |
| ORBIMED ADVISORS LLC | $5.364.687 | 909.269 | 14,79% | Azioni |
| Cable Car Capital, LP | $4.611.434 | 781.599 | 12,71% | Azioni |
| Omega Fund Management, LLC | $2.686.630 | 455.361 | 7,41% | Azioni |
| RTW INVESTMENTS, LP | $1.973.226 | 334.445 | 5,44% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.891.056 | 320.518 | 5,21% | Azioni |
| Trails Edge Capital Partners, LP | $1.663.824 | 282.004 | 4,59% | Azioni |
| BML Capital Management, LLC | $1.184.307 | 200.730 | 3,26% | Azioni |
| Monashee Investment Management LLC | $1.134.830 | 192.344 | 3,13% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $512.887 | 86.930 | 1,41% | Azioni |
| BlackRock, Inc. | $405.253 | 68.687 | 1,12% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $393.329 | 66.666 | 1,08% | Azioni |
| CITADEL ADVISORS LLC | $328.099 | 55.610 | 0,90% | Azioni |
| NEA Management Company, LLC | $295.030 | 50.005 | 0,81% | Azioni |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $295.000 | 50.000 | 0,81% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $251.032 | 42.542 | 0,69% | Azioni |
| HSBC HOLDINGS PLC | $208.449 | 34.228 | 0,57% | Azioni |
| Sofinnova Investments, Inc. | $188.116 | 31.884 | 0,52% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $162.103 | 27.475 | 0,45% | Azioni |
| Rangeley Capital, LLC | $118.531 | 20.090 | 0,33% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $117.410 | 19.900 | 0,32% | Azioni |
| Aldebaran Capital, LLC | $106.932 | 18.124 | 0,29% | Azioni |
| Shay Capital LLC | $106.672 | 18.080 | 0,29% | Azioni |
| GOLDMAN SACHS GROUP INC | $91.362 | 15.485 | 0,25% | Azioni |
| NORTHERN TRUST CORP | $66.499 | 11.271 | 0,18% | Azioni |
| BARCLAYS PLC | $63.702 | 10.797 | 0,18% | Azioni |
| MORGAN STANLEY | $44.592 | 7.558 | 0,12% | Azioni |
| UBS Group AG | $29.199 | 4.949 | 0,08% | Azioni |
| VANGUARD GROUP INC | $4.154 | 602 | 0,01% | Azioni |
| Tower Research Capital LLC (TRC) | $3.983 | 675 | 0,01% | Azioni |
| Vanguard Global Advisers, LLC | $3.552 | 602 | 0,01% | Azioni |
| Caitong International Asset Management Co., Ltd | $2.738 | 464 | 0,01% | Azioni |
| NewEdge Advisors, LLC | $944 | 160 | 0,00% | Azioni |
| JPMORGAN CHASE & CO | $425 | 70 | 0,00% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $142 | 24 | 0,00% | Azioni |
Insider aziendali 20 insider · 8 dirigenti · 11 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Mark Manfredi | President & CEO | 01 Febbraio 2024 A | — | 0 | 0 | $0 |
| Jotin Marango | Chief Financial Officer | 25 Luglio 2025 D | 11.146 | 0 | 0 | $0 |
| Robert B Lally | Principal Accounting Officer | 17 Luglio 2026 S | 55.582 | 0 | 2 | $-17.334 |
| Caroline Germa | Chief Medical Officer | 01 Marzo 2024 A | — | 0 | 0 | $0 |
| Jeffrey Ecsedy | Chief Development Officer | 01 Febbraio 2024 A | — | 0 | 0 | $0 |
| Xiaoyan Michelle Zhang | Chief Scientific Officer | 03 Gennaio 2023 A | 44.475 | 0 | 0 | $0 |
| Sergio L. Santillana | Chief Medical Officer | 03 Gennaio 2023 A | — | 0 | 0 | $0 |
| Maude Tessier | Chief Business Officer | 02 Febbraio 2022 A | 100.578 | 0 | 0 | $0 |
| David P Bonita | Direttore | 16 Giugno 2026 A | 5.582.144 | 0 | 0 | $0 |
| Jonathan Jian Wang | Direttore | 16 Giugno 2026 A | — | 0 | 0 | $0 |
| Otello Stampacchia | Direttore | 16 Giugno 2026 A | 2.249.123 | 0 | 0 | $0 |
| Joseph P Slattery | Direttore | 16 Giugno 2026 A | 16.000 | 1 | 0 | $95.840 |
| Maria Koehler | Direttore | 07 Giugno 2024 A | — | 0 | 0 | $0 |
| Richard Wooster | Direttore | 07 Giugno 2024 A | — | 0 | 0 | $0 |
| Iain D. Dukes | Direttore | 07 Giugno 2024 A | — | 0 | 0 | $0 |
| Owen Hughes | Direttore | 07 Giugno 2024 A | — | 0 | 0 | $0 |
| FORMELA JEAN FRANCOIS | Direttore | 07 Giugno 2024 A | 1.241.935 | 0 | 0 | $0 |
| Ronald C Renaud JR | Direttore | 09 Giugno 2022 A | — | 0 | 0 | $0 |
| Yanina Grant-Huerta | — | 14 Agosto 2026 A | 104.000 | 0 | 0 | $0 |
| Kristin Yarema | — | 14 Agosto 2026 A | 493.705 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VI LLC, OrbiMed Genesis GP LLC, ORBIMED CAPITAL LLC ×7 depositi | 29 Aprile 2026 | 13,10% | Modifica | — | SEC |
| Omega Fund VI, L.P., Omega Fund VI GP, L.P., Omega Fund VI GP Manager, Ltd., Claudio Nessi, Otello Stampacchia | 21 Aprile 2026 | 8,40% | Deposito iniziale | — | SEC |
| Atlas Venture Fund X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Fund XI, L.P., Atlas Venture Associates XI, L.P., Atlas Venture Associates XI, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC ×2 depositi | 29 Luglio 2025 | 2,10% | Modifica | — | SEC |
| BML Investment Partners, L.P., Leonard Braden Michael ×2 depositi | 28 Luglio 2025 | 1,90% | Modifica | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 3 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.